Cefpodoxime
Cefpodoxime.JPG

Cefpodoxime

CLINICAL USE

Antibacterial agent

DOSE IN NORMAL RENAL FUNCTION

100–200 mg every 12 hours

PHARMACOKINETICS

  • Molecular weight                           :557.6 (as proxetil)
  • %Protein binding                           :20–40
  • %Excreted unchanged in urine     : 80
  • Volume of distribution (L/kg)       :0.6–1.2
  • half-life – normal/ESRD (hrs)      :2.4/26

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : 100–200 mg every 24 hours

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in GFR <10 mL/min
  • HD                     :Dialysed. Dose as in GFR
  • <10           : mL/min
  • HDF/high flux   :Dialysed. Dose as in GFR
  • <10           : mL/min
  • CAV/VVHD      :Dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsAnticoagulants: effects of coumarins may be enhanced

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    Take with food Antacids and H 2-blockers should be taken 2–3 hours after administration of cefpodoxime.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs